Methionylmethionine (Met-Met) is a dipeptide consisting of two methionine amino acids linked by a peptide bond. It is a naturally occurring compound found in various biological systems and has been studied for its potential therapeutic applications. Met-Met is known to be a precursor for the biosynthesis of methionine, an essential amino acid required for protein synthesis and other metabolic processes. In addition to its role in protein synthesis, Met-Met has been implicated in various biological functions, including antioxidant activity, neuroprotection, and anti-inflammatory effects. Its antioxidant properties are attributed to its ability to scavenge free radicals, while its neuroprotective effects may be related to its ability to protect neurons from damage caused by oxidative stress. Met-Met is also being investigated for its potential therapeutic benefits in conditions such as Parkinson's disease, Alzheimer's disease, and cancer. However, further research is needed to fully understand the mechanisms of action and potential therapeutic applications of Met-Met.'
methionylmethionine: has growth-promoting ability equal to DL-methionine; RN given refers to (DL-Met-DL-Met)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Met-Met : A dipeptide formed from two L-methionine residues. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 104294 |
CHEMBL ID | 159019 |
SCHEMBL ID | 1157690 |
MeSH ID | M0106909 |
Synonym |
---|
met-met |
nsc-522615 |
l-methionine, n-l-methionyl- |
methionylmethionine |
nsc522615 |
nsc-522618 |
nsc522618 |
chembl159019 |
2-(2-amino-4-methylsulfanyl-butyrylamino)-4-methylsulfanyl-butyric acid |
bdbm50085087 |
2-[(2-amino-4-methylsulfanylbutanoyl)amino]-4-methylsulfanylbutanoic acid |
einecs 258-124-8 |
methionine, methionyl- |
52715-93-2 |
n-dl-methionyl-dl-methionine |
SCHEMBL1157690 |
h-dl-met-dl-met-oh |
ZYTPOUNUXRBYGW-UHFFFAOYSA-N |
methionine-methionine dipeptide |
m-m dipeptide |
methionine methionine dipeptide |
mm dipeptide |
FT-0771536 |
2-(2-amino-4-(methylthio)butanamido)-4-(methylthio)butanoic acid |
dl-methionyl-dl-methionine |
F84478 |
DTXSID50886013 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.79) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |